~~<i id='F239CE9868'><strike id='F239CE9868'><tt id='F239CE9868'><pre id='F239CE9868'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：comprehensive 2025-08-23 08:57:48 - browse：3

Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial — likely a major disappointment for patients and doctors who have been desperately awaiting the treatment for years.

The company said all patients in the study improved and that secondary measurements indicated the drug was having an effect. Nevertheless, the results are likely to raise questions about whether the Food and Drug Administration will expand access to the medicine.

Trading in Sarepta shares was halted at $107 with the release of the study results.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： CommonSpirit Health keeps growing, even as it loses money

focus

hotspot

focus

leisure time

focus

Wikipedia

Thematchstick-sized,implantabledevicefromIntarciaTherapeuticsreleasesasteady,continuous,andlow-doses

WSS

CommonSpirit Health keeps growing, even as it loses money

Novo acquires Inversago for up to $1 billion

Timeline: Special counsel's investigation into Trump's handling of classified documents

Experts study whether long Covid risk adds up with each reinfection

EpiPen alternative approval delay highlights citizen petition issue

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

explore

fashion

focus

Alkermes shareholders re

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

The high cost of giving birth even with insurance

Microbiome research is starting to find links to chronic diseases

How to save PrEP access — and even expand it

Newly revealed memo details efforts to keep Trump in power following election loss

Trump demands the U.S. pay no more for drugs than other countries … again

GOP presidential candidates start declaring their loyalty

At least 13 dead in Texas as scorching temps continue

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

hotspot

Covid's long

Pharma budget tightening trickles down to Doximity

Large hospital system sues Multiplan for low

Senate HELP committee spars over health care workforce policies

Second xenotransplant done with gene

Changes to biosimilar regulatory framework must prioritize patients

focus

leisure time

focus

Wikipedia